World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
116
Citations
52152
World Ranking
673
National Ranking
404

Medicine

D-Index
118
Citations
53415
World Ranking
4048
National Ranking
2217

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2010 - Fellow of the American Statistical Association (ASA)

Overview

Susan Groshen is affiliated with the University of Southern California in the United States. Their research is primarily situated within the field of Medicine, with significant contributions in Oncology, Surgery, Neurology, Pulmonary and Respiratory Medicine, and Cancer Research. Their work spans multiple topics including Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, and Health Systems, Economic Evaluations, and Quality of Life.

Their recent papers demonstrate a focus on cancer and neuroblastoma treatments, with notable publications such as:

  • "Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients" (2023, Journal of Clinical Oncology)
  • "Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials" (2021, European Urology)
  • "Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results" (2023, Nature Medicine)
  • "Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium" (2021, Journal of Clinical Oncology)
  • "Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis" (2020, Journal of Neuroinflammation)

Frequent co-authors working alongside Susan Groshen include Denice Tsao-Wei, Julie R. Park, Katherine K. Matthay, Araz Marachelian, and Meaghan Granger, indicating collaborative research efforts in related fields.

The primary venues for their publications are:

  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Annals of Oncology
  • Gynecologic Oncology
  • Research Square (Research Square)

Their research spans across multiple subfields of medicine, focusing on clinical oncology and surgery among others.

Susan Groshen was awarded the title of Fellow of the American Statistical Association (ASA) in 2010.

Best Publications

  • Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

    John P. Stein;Gary Lieskovsky;Richard Cote;Susan Groshen

  • Colorectal Tumors Responding to 5-Fluorouracil Have Low Gene Expression Levels of Dihydropyrimidine Dehydrogenase, Thymidylate Synthase, and Thymidine Phosphorylase

    Dennis Salonga;Kathleen D. Danenberg;Martin Johnson;Ralf Metzger

  • Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer

    David Esrig;Donald Elmajian;Susan Groshen;John A. Freeman

  • The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast

    Melvin J. Silverstein;Michael D. Lagios;Susan Groshen;James R. Waisman

  • A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan

    Sebastian Brandhorst;In Young Choi;Min Wei;Chia Wei Cheng

  • ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy

    Yoshinori Shirota;Jan Stoehlmacher;Jan Brabender;Yi-Ping Xiong

  • Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

    F M Muggia;J D Hainsworth;S Jeffers;P Miller

  • Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

    Agustin A. Garcia;Hal Hirte;Gini Fleming;Dongyun Yang

  • Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.

    Sheeja T. Pullarkat;Jan Stoehlmacher;V. Ghaderi;Yi Ping Xiong

  • ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

    Ralf Metzger;Cynthia Gail Leichman;Kathleen D. Danenberg;Peter V. Danenberg

  • The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer : a prospective comparative trial

    Donald G. Skinner;John R. Daniels;Christy A. Russell;Gary Lieskovsky

  • Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

    T. Safra;F. Muggia;S. Jeffers;D. D. Tsao-Wei

  • Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.

    Cynthia Gail Leichman;Heinz-Josef Lenz;Lawrence Leichman;Kathleen Danenberg

  • FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent Cetuximab

    Wu Zhang;Michael Gordon;Anne M. Schultheis;Dong Yun Yang

  • Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

    Kristin Sanderson;Ronald Scotland;Peter Lee;Dongxin Liu

  • Risk Factors for Patients With Pelvic Lymph Node Metastases Following Radical Cystectomy With En Bloc Pelvic Lymphadenectomy: The Concept of Lymph Node Density

    John P. Stein;Jie Cai;Susan Groshen;Donald G. Skinner

  • p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

    David Esrig;Charles H. Spruck;Peter W. Nichols;Benjaporn Chaiwun

  • Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis

    Bernard H. Bochner;Richard J. Cote;Noel Weidner;Susan Groshen

  • Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells

    Henry K. Lin;Siyang Zheng;Anthony J. Williams;Marija Balic

  • Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease.

    Min Wei;Sebastian Brandhorst;Mahshid Shelehchi;Hamed Mirzaei

Frequent Co-Authors

David I. Quinn
David I. Quinn University of Southern California
Donald G. Skinner
Donald G. Skinner University of Southern California
Richard J. Cote
Richard J. Cote Washington University in St. Louis
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Peter V. Danenberg
Peter V. Danenberg University of Southern California
Kathleen D. Danenberg
Kathleen D. Danenberg University of Southern California
John M. Maris
John M. Maris Children's Hospital of Philadelphia
C. Patrick Reynolds
C. Patrick Reynolds Texas Tech University Health Sciences Center
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond medical school, online programs are opening new doors. Many healthcare professionals consider advancing their education with a Master of Health Administration. If you want to move into leadership roles, take a look at some of the best online mha programs that are CAHME-accredited for high standards.

Nurses looking to progress in the field now have flexible options, too. The rn to bsn online programs without clinicals are ideal for working RNs who need to balance education and job commitments, often completing their degree faster.

For nursing professionals aiming for advanced practice or leadership, Doctor of Nursing Practice degrees are in demand. Check out the online dnp programs that can be finished in a shorter time frame, as well as the easiest dnp programs that emphasize accessibility while maintaining quality education.

These flexible online pathways make it easier than ever to grow your healthcare career and adapt to the evolving needs of the industry.

Best Scientists Citing Susan Groshen

Trending Scientists

Recently Published Articles